← Open Payments lookup

CHRISTINA SCHMUTZ: Open Payments

NPI 1962982348 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,566 in 71 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $341 · 2025 $1,566

Food & beverage: $1,423Education: $93Long term medical supply or device loan: $50
CompanyPaymentsAmount
Amgen Inc.9$201
Lilly USA, LLC8$167
AstraZeneca Pharmaceuticals LP7$140
Novartis Pharmaceuticals Corporation4$104
Abbott Laboratories3$84
GlaxoSmithKline, LLC.5$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$81
Astellas Pharma US Inc1$79
Actelion Pharmaceuticals US, Inc.3$72
Edwards Lifesciences Corporation2$64

Products named: EVENITY, LEQVIO, TRELEGY ELLIPTA, XIFAXAN, AIRSUPRA, UPTRAVI, MOUNJARO, Korlym.

Industry payments across WA — which companies pay providers there.